Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes

Oncogene

Volumn 30, Issue 20, 2011, Pages 2333-2344

  Kalamarides, M ^a,b,c   Stemmer Rachamimov, A O ^d   Niwa Kawakita, M ^a,b   Chareyre, F ^a,b   Taranchon, E ^a,b   Han, Z Y ^a,b   Martinelli, C ^a,b   Lusis, E A ^e   Hegedus, B ^e,g   Gutmann, D H ^e   Giovannini, M ^a,b,f  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c BEAUJON HOSPITAL   (France)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HOUSE EAR INSTITUTE   (United States)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

arachnoid; brain tumours; neurofibromatosis type 2

Indexed keywords

PROSTAGLANDIN D SYNTHASE; TUMOR MARKER;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE INACTIVATION; GENE MUTATION; HISTOLOGY; HUMAN; MENINGIOMA; MOUSE; NF2 GENE; NONHUMAN; ONCOGENE; POSTNATAL DEVELOPMENT; PRIMORDIUM; PRIORITY JOURNAL;

ANIMALS; ARACHNOID; CELL LINEAGE; GENES, NEUROFIBROMATOSIS 2; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MENINGEAL NEOPLASMS; MENINGIOMA; MICE; MICE, TRANSGENIC; STEM CELLS; TIME FACTORS;

MURINAE;

EID: 79956096479     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.609     Document Type: Article

References (44)

1. Akagi K, Sandig V, Vooijs M, Van der Valk M, Giovannini M, Strauss M et al. (1997). Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res 25: 1766-1773. (Pubitemid 27303358)
2. Angelov DN, Vasilev VA. (1989). Morphogenesis of rat cranial meninges. A light- and electron-microscopic study. Cell Tissue Res 257: 207-216. (Pubitemid 19161346)
3. Beuckmann CT, Lazarus M, Gerashchenko D, Mizoguchi A, Nomura S, Mohri I et al. (2000). Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat. J Comp Neurol 428: 62-78.
4. Catala M. (1998). Embryonic and fetal development of structures associated with the cerebro-spinal fluid in man and other species. Part I: the ventricular system, meninges and choroid plexuses. Arch Anat Cytol Pathol 46: 153-169. (Pubitemid 28222051)
5. Couly GF, Le Douarin NM. (1987). Mapping of the early neural primordium in quail-chick chimeras. II. The prosencephalic neural plate and neural folds: implications for the genesis of cephalic human congenital abnormalities. Dev Biol 120: 198-214. (Pubitemid 17027110)
6. Da Cruz MJ, Hardy DG, Moffat DA. (2000). Clinical presentation of a group of NF2 patients to a tertiary referral skull base unit. Br J Neurosurg 14: 101-104. (Pubitemid 30258896)
7. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS et al. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
8. Eguchi N, Minami T, Shirafuji N, Kanaoka Y, Tanaka T, Nagata A et al. (1999). Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci USA 96: 726-730. (Pubitemid 29061276)
9. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D et al. (1992). A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29: 841-846. (Pubitemid 23035205)
10. Fevre-Montange M, Champier J, Durand A, Wierinckx A, Honnorat J, Guyotat J et al. (2009). Microarray gene expression profiling in meningiomas: differential expression according to grade or histo-pathological subtype. Int J Oncol 35: 1395-1407.
11. Giovannini M, Robanus-Maandag E, Van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L et al. (2000). Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14: 1617-1630. (Pubitemid 30460911)
12. Gutmann DH, Giordano MJ, Fishback AS, Guha A. (1997). Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 49: 267-270. (Pubitemid 27328718)
13. Haines DE, Harkey HL, al-Mefty O. (1993). The 'subdural' space: a new look at an outdated concept. Neurosurgery 32: 111-120. (Pubitemid 23020006)
14. Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A. (2006). NF2 mutations in secretory and other rare variants of meningiomas. Brain Pathol 16: 15-19.
15. Hoffmann A, Bachner D, Betat N, Lauber J, Gross G. (1996). Developmental expression of murine beta-trace in embryos and adult animals suggests a function in maturation and maintenance of blood-tissue barriers. Dev Dyn 207: 332-343. (Pubitemid 26378335)
16. Kalamarides M, Niwa-Kawakita M, Leblois H, Abramowski V, Perricaudet M, Janin A et al. (2002). Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev 16: 1060-1065. (Pubitemid 34507195)
17. Kalamarides M, Stemmer-Rachamimov AO, Takahashi M, Han ZY, Chareyre F, Niwa-Kawakita M et al. (2008). Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. Brain Pathol 18: 62-70.
18. Kamiryo T, Orita T, Nishizaki T, Aoki H. (1990). Development of the rat meninx: experimental study using bromodeoxyuridine. Anat Rec 227: 207-210. (Pubitemid 20153546)
19. Kawashima M, Suzuki SO, Yamashima T, Fukui M, Iwaki T. (2001). Prostaglandin D synthase (beta-trace) in meningeal hemangioper-icytoma. Mod Pathol 14: 197-201. (Pubitemid 32246824)
20. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A. (2001). Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413: 83-86. (Pubitemid 32843492)
21. Kros J, de Greve K, Van Tilborg A, Hop W, Pieterman H, Avezaat C et al. (2001). NF2 status of meningiomas is associated with tumour localization and histology. J Pathol 194: 367-372. (Pubitemid 32624564)
22. Krutilkova V, Trkova M, Fleitz J, Gregor V, Novotna K, Krepelova A et al. (2005). Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer 41: 1597-1603. (Pubitemid 40981842)
23. Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, Lee E et al. (1996). Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci USA 93: 5860-5865. (Pubitemid 26190768)
24. Le Lievre CS, Le Douarin NM. (1975). Mesenchymal derivatives of the neural crest: analysis of chimaeric quail and chick embryos. J Embryol Exp Morphol 34: 125-154.
25. Lee JH, Sade B, Choi E, Golubic M, Prayson R. (2006). Meningothe-lioma as the predominant histological subtype of midline skull base and spinal meningioma. J Neurosurg 105: 60-64. (Pubitemid 43979098)
26. Louis DN, Scheitauer BW, Budka H, von Deimling A, Kepes JJ. (2000). Meningiomas. In: Kleihues P, Cavenee WK (eds). Pathology and Genetics of Tumours of the Nervous System. IARC Press: Lyon, pp 176-184.
27. Marino S, Vooijs M, Van Der Gulden H, Jonkers J, Berns A. (2000). Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev 14: 994-1004. (Pubitemid 30253007)
28. McBratney-Owen B, Iseki S, Bamforth SD, Olsen BR, Morriss-Kay GM. (2008). Development and tissue origins of the mammalian cranial base. Dev Biol 322: 121-132.
29. McClatchey AI, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT et al. (1998). Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12: 1121-1133. (Pubitemid 28194048)
30. McLone DG, Bondareff W. (1975). Developmental morphology of the subarachnoid space and contiguous structures in the mouse. Am J Anat 142: 273-293.
31. Nakamura M, Roser F, Michel J, Jacobs C, Samii M. (2003). The natural history of incidental meningiomas. Neurosurgery 53: 62-70; discussion 70-1.
32. Nakasu S, Hirano A, Shimura T, Llena JF. (1987). Incidental meningiomas in autopsy study. Surg Neurol 27: 319-322. (Pubitemid 17049781)
33. Olivero WC, Lister JR, Elwood PW. (1995). The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 83: 222-224.
34. Pietri T, Eder O, Blanche M, Thiery JP, Dufour S. (2003). The human tissue plasminogen activator-Cre mouse: a new tool for targeting specifically neural crest cells and their derivatives in vivo. Dev Biol 259: 176-187. (Pubitemid 36703152)
35. Robanus-Maandag E, Giovannini M, Van der Valk M, Niwa-Kawakita M, Abramowski V, Antonescu C et al. (2004). Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin. Oncogene 23: 6541-6547. (Pubitemid 39265517)
36. Ruttledge MH, Xie YG, Han FY, Peyrard M, Collins VP, Nordenskjold M et al. (1994). Deletions on chromosome 22 in sporadic meningioma. Genes Chromosomes Cancer 10: 122-130. (Pubitemid 24155982)
37. Schwechheimer K, Kartenbeck J, Moll R, Franke WW. (1984). Vimentin filament-desmosome cytoskeleton of diverse types of human meningiomas. A distinctive diagnostic feature. Lab Invest 51: 584-591. (Pubitemid 15175392)
38. Stuart JE, Lusis EA, Scheck AC, Coons SW, Lal A, Perry A et al (2010). Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays. J Neuropathol Exp Neurol (e-pub ahead of print 11 December 2010).
39. Tohma Y, Yamashima T, Yamashita J. (1992). Immunohistochemical localization of cell adhesion molecule epithelial cadherin in human arachnoid villi and meningiomas. Cancer Res 52: 1981-1987.
40. Urade Y, Kitahama K, Ohishi H, Kaneko T, Mizuno N, Hayaishi O. (1993). Dominant expression of mRNA for prosta-glandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc Natl Acad Sci USA 90: 9070-9074. (Pubitemid 23306453)
41. Vandenabeele F, Creemers J, Lambrichts I. (1996). Ultrastructure of the human spinal arachnoid mater and dura mater. J Anat 189(Part 2): 417-430. (Pubitemid 26364697)
42. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP et al. (2007). Incidental findings on brain MRI in the general population. N Engl J Med 357: 1821-1828. (Pubitemid 350044802)
43. Yamashima T, Sakuda K, Tohma Y, Yamashita J, Oda H, Irikura D et al. (1997). Prostaglandin D synthase (beta-trace) in human arachnoid and meningioma cells: roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process. J Neurosci 17: 2376-2382. (Pubitemid 27137404)
44. Yoshida T, Vivatbutsiri P, Morriss-Kay G, Saga Y, Iseki S. (2008). Cell lineage in mammalian craniofacial mesenchyme. Mech Dev 125: 797-808.